Clinical Studies
-
Validation of a Genomic Marker for Necrotizing Meningoencephalitis in Pugs
ClosedSingle Day Clinic: March 7, 2020.
Study Details
Ethos Discovery is pursuing an investigation into the use of a novel therapy for NME in pugs. This study will only consist of a one-time visit for the blood sample collection. Participating pugs will get free wellness and neurological exams, general bloodwork, and NME-risk factor screening. -
Rapamycin for the Treatment of Cancer in Dogs
OpenThis study seeks to understand the intestinal absorption potential of a novel formulation of rapamycin when administered to dogs with naturally occurring cancer. The data from this study will be used to define an ideal dose of the drug to use in future cancer clinical studies.
Study Details -
Sorafenib for the Treatment of Solid Tumors in Dogs
ClosedWe have previously reported on the tolerability and hints of clinical activity of Sorafenib in dogs with cancer. This background provides a rationale for the further study of Sorafenib in dogs with cancer. In this study we seek to define an optimal dosing schedule for Sorafenib and will assess its tolerability and activity in dogs with solid tumors.
Study Details -
Assay for DNA using Exosome for Pancreatitis Testing (ADEPT)
ClosedThis is study is looking to develop a novel diagnostic test for canine pancreatitis through the identification of genomic markers called exosomes.
Study Details -
Collection of Biological Specimens from Dogs Diagnosed with Cancer, but Not Scheduled to Undergo Surgery for Tumor Removal
No Longer EnrollingThis study will compare markers in the blood that are specific to cancer but not found in healthy dogs, before and after treatment for cancer has begun.
Study Details -
Evaluating a New Medication to Control Pain Associated with Osteoarthritis of the Elbow in Dogs
ClosedThe study aims to confirm the effectiveness and safety of a new medicine to control pain associated with osteoarthritis of the elbow in dogs.
Study Details